TherapeuticsMD (TXMD) FCF Margin (2011 - 2026)
TherapeuticsMD (TXMD) posted FCF Margin of 130.39% for Q1 2026, up 210.49% on a QoQ basis from 41.99% in Q4 2025, and down 4748.0% year-over-year from 2.81% in Q1 2025.
TherapeuticsMD (TXMD) FCF Margin (2011 - 2026) Analysis & Trends
TherapeuticsMD's FCF Margin history runs 16 years deep, the most recent figure standing at 130.39% for Q1 2026.
- Quarterly FCF Margin fell 4748.0% year-over-year to 130.39% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 80.5% (down 3346.0% YoY) and the FY2025 annual result came in at 81.2%, up 1476.0% from the prior year.
- FCF Margin was 130.39% for Q1 2026 at TherapeuticsMD, up from 41.99% in the prior quarter.
- Across five years, FCF Margin topped out at 5004.52% in Q3 2022 and bottomed at 10013.21% in Q3 2023.
- A 5-year average of 985.8% and a median of 2.55% in 2024 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2023 — FCF Margin tumbled 1501773 bps — and 2024, when it soared 1000023 bps.
- TherapeuticsMD's FCF Margin stood at 32.99% in 2022, then slumped by 4799 bps to 1550.32% in 2023, then jumped by 100 bps to 2.55% in 2024, then surged by 1548 bps to 41.99% in 2025, then jumped by 210 bps to 130.39% in 2026.
- Business Quant data shows TXMD's FCF Margin at 130.39% in Q1 2026, 41.99% in Q4 2025, and 127.42% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -5.22% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 12.86% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5.35% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 46.54% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 9.93% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 17.73% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.77% |
| 10 | TherapeuticsMD | 280,159.99 | -8.14 Mn | - | 130.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 130.39% |
| Dec 31, 2025 | 41.99% |
| Sep 30, 2025 | 127.42% |
| Jun 30, 2025 | 40.02% |
| Mar 31, 2025 | 177.86% |
| Dec 31, 2024 | 2.55% |
| Sep 30, 2024 | -12.98% |
| Jun 30, 2024 | 620.94% |
| Mar 31, 2024 | -73.16% |
| Dec 31, 2023 | -1,550.32% |
| Sep 30, 2023 | -10,013.21% |
| Jun 30, 2023 | -665.68% |
| Mar 31, 2023 | -2,096.15% |
| Dec 31, 2022 | 32.99% |
| Sep 30, 2022 | 5,004.52% |
| Jun 30, 2022 | -5,948.28% |
| Mar 31, 2022 | -2,577.55% |
| Dec 31, 2021 | 257.00% |
| Sep 30, 2021 | -150.17% |
| Jun 30, 2021 | -115.53% |